Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis

Astragaloside IV (AS-IV), the essential active component of astragalus, possesses diverse biological activities that have beneficial effects against cardiovascular disease. Here, we conducted a preclinical systematic review of 15 studies including 577 animals to establish the efficacy and potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Zhuang, Wang, Zi-Hao, Deng, Li-Hui, Zheng, Qun, Zheng, Guo-Qing, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892970/
https://www.ncbi.nlm.nih.gov/pubmed/31849654
http://dx.doi.org/10.3389/fphar.2019.01388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892970/
https://www.ncbi.nlm.nih.gov/pubmed/31849654
http://dx.doi.org/10.3389/fphar.2019.01388

Ejemplares similares